Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
XiFin
| Company | XiFin |
|---|---|
| Name of laboratory information system | XiFin Empower LIS |
| Contact | Joseph Nollar |
| City, State | San Diego, CA |
| Phone | 858-793-5700 |
| Website | |
| Company provides list of client sites to potential customers on request | yes (partial list of comparable sites with no restrictions regarding its use) |
| Updates covered by standard software maintenance fee | all updates |
| Schedule for providing standard software updates to clients | monthly |
| Clients must install updates in specified timespans to avoid maintenance fee increase | yes |
| Fee for software modifications to comply with federal regulations and laws | no |
| Year company began selling LISs (any brand or model) | 2004 |
| Most recent LIS go-live at a client site (based on August 2025 survey deadline) | Feb-2025 |
| Last product release or update for featured LIS | 81 |
| No. of U.S. sales and installations of LIS between August 2024–July 2025 | 2 sales/2 installations |
| Total No. of U.S. sites operating LIS (hospitals/independent labs/clinics or group practices/public health labs/other sites) | 91 (0/68/22/0/1–veterinary pathology) |
| • Approx. percentage of high-vol.* U.S. site installs/Low-vol.** U.S. site installs | 40%/60% |
| Foreign locations where company actively markets LIS for clinical lab use | none |
| • Foreign locations where LIS has been installed for clinical lab use | — |
| Human languages (other than English) supported by LIS | — |
| Approximate No. of employees in entire company | 1, 200 |
| Central hardware or service type | software-as-a-service |
| Programming languages and development applications or environments | C# |
| Operating system(s) | Windows Server 2022 (hosted) |
| Databases | Microsoft SQL |
| System includes full transaction logging | yes |
| • Chemistry/Hematology/Print barcoded collection labels | installed at client sites (all 3 features) |
| • Microbiology/Public health microbiology | installed at client sites/installed at client sites |
| • Blood bank donor/Blood bank transfusion | not available/not available |
| • Surgical pathology/Cytology | installed at client sites/installed at client sites |
| • Molecular pathology/Cytogenetics/Flow cytometry | installed at client sites (all 3 features) |
| • EHR interface for admission/discharge/transfer (ADT) | installed at client sites |
| • EHR interface for order entry/EHR interface for results reporting | installed at client sites/installed at client sites |
| • EHR interface+GQ3:GQ15 for packaging results into PDF format | installed at client sites |
| • EHR interface for packaging results into CDA1 format/CDA2 format | installed at client sites/installed at client sites |
| • Ad hoc reporting/Rules-based system | installed at client sites/installed at client sites |
| • Management and statistical reporting/Client services or CRM module | installed at client sites/installed at client sites |
| • POL link or Web portal to physician offices/Patient Web portal | installed at client sites/available via XiFin patient portal |
| • Commercial reference lab functionality/Compliance checking | installed at client sites/installed at client sites |
| • Comprehensive billing and accounts receivable or RCM | • Comprehensive billing and accounts receivable or RCM |
| • Materials management and inventory/Test partition | installed at client sites/installed at client sites |
| • Remote faxing/Remote printing | installed at client sites/installed at client sites |
| • HIPAA-standard transaction formats | installed at client sites |
| • Web-based remote inquiry of reports/Web access for order entry | installed at client sites/installed at client sites |
| • Management and tracking of specimens within lab/Before arriving in lab | installed at client sites/installed at client sites |
| • QA tools/Environmental health | installed at client sites/not available |
| • Interfaces for sending orders from primary lab to reference lab, handling results return, and status updates | installed at client sites |
| • Business analytics/Clinical analytics | available via XiFin Empower IQ/installed at client sites |
| • Ability to schedule patient for test collection/Patient-based test registration | not available/available via XiFin patient portal |
| • Ability to coordinate with nurses for collections that phlebotomists cannot perform | not available |
| • Interfaces with public health databases using ELR as part of Promoting Interoperability | installed at client sites |
| • Results for tests run using different methods show method on clinical reports | installed at client sites |
| Barcode symbologies supported by LIS | Code 39, Code 128, DataMatrix |
| Ability to use artificial intelligence (e.g., machine-learning software) with LIS | yes (integrates with Paige AI, Proscia, other AI providers; XiFin Empower IQ supports AI analytics for LIS) |
| • Microbiology (culture and sensitivity) | yes |
| • Other reportable diseases or conditions (e.g., blood lead, immunology, etc.) | yes |
| • Tumor diagnosis and case data to regional cancer registry*** | yes |
| LIS bidirectionally interfaces to other IT vendors’ lab systems in live sites | yes |
| LIS uses third-party middleware for LIS–instrument interfaces | combination of direct interfaces and third-party middleware (Data Innovations) |
| Lab automation systems or workcells to which LIS has a direct interface | Beckman Coulter, Siemens, Sysmex, Thermo Scientific, Olympus America, Roche, Tecan |
| LIS supports use of SNOMED CT | yes, for all cases |
| LIS automatically ingests and applies electronic updates of tables and rules from organizations and government agencies | yes (CPT, ICD codes) |
| LIS allows for image capture, display, reporting | yes |
| LIS provides indexed field in each test definition for LOINC code | yes |
| Client gets copy of source code/User group that meets on established schedule | no/yes (via webinar) |
| Qualified users or third parties can modify or augment LIS functions or features | yes (client users) |
| Methods by which users can tailor LIS in their own setting | ad hoc query tools, user-defined interfaces, dictionary settings, read/write privileges, workflow configuration, tailored worklists, case types, data-entry screens, others |
| Distinguishing product features (supplied by company) | cloud solution that includes monthly upgrades; configurable workflows; scalability; CP, AP, molecular, and NGS; comprehensive reports that combine multiple test results into a single report for clinicians |
| Notes | †formerly XiFin LIS |